Skip to content
WeighLab
Provider review

Hers Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

Hers (Hims & Hers Health, NYSE: HIMS) now sells only FDA-approved branded GLP-1 medications for weight loss — Wegovy, Zepbound, Ozempic, Mounjaro, and the new orforglipron pill 'Foundayo' — rather than compounded semaglutide.

In this review
Check Hers prices Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.

Prices at a glance

Semaglutide
$348/moBrand Wegovy, plus a separate fee
Tirzepatide
$448/moBrand Zepbound, plus a separate fee
Coverage
Not available in all 50 states; confirm your state
Brand-name
Yes

Semaglutide · estimated annual cost

$4,176

Tirzepatide · estimated annual cost

$5,376

Who Hers may suit

Women who want brand-name Wegovy, Zepbound or a GLP-1 pill from a mainstream telehealth brand, and who will pay a monthly membership on top.

Where the value is

  • Sells only FDA-approved branded medications (Wegovy, Zepbound, Ozempic, Mounjaro) rather than compounded versions
  • Multiple formats per drug (pill vs pen/vial), including a newer pill option and microdosing plan
  • Large, publicly traded parent (Hims & Hers Health) with an established clinical/support infrastructure

The tradeoffs

  • The advertised 'From $X/mo' price is medication-only — a mandatory membership fee ($39 first month, then $149/mo, billed separately) is layered on top and roughly doubles the real steady-state monthly cost
  • No compounded, lower-cost semaglutide or tirzepatide option
  • The membership fee 'does not include or guarantee a prescription,' so it can recur even in a month without a fresh prescription
  • FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025; the letter is public in FDA's warning-letter database

What you'll pay at Hers

Hers sells brand-name GLP-1s, and every price it advertises is for the medication alone. On top of that you need the Hers Weight Loss Membership, which costs $39 for the first month and then renews at $149 a month. The two are billed separately, and Hers says plainly that the membership doesn't guarantee a prescription.

Here's how that adds up once the first month is over:

MedicationMedication fromWith the $149 membership
Wegovy pen$199/mo$348/mo
Zepbound KwikPen$299/mo$448/mo

Those are starting prices. Hers notes that pricing may change with your dose, so ask what the higher steps cost before you commit. The Wegovy pill also starts at $149 a month for the medication, and Hers lists Foundayo, Zepbound vials, Ozempic and a lower-dose "microdosing" plan too. Ozempic and Mounjaro are only prescribed to people who meet the diabetes-related criteria.

Considering Hers?

Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.

What the membership includes

The $149 covers round-the-clock messaging with licensed providers, dose changes as you go, help with side effects and in-app weight tracking. New members can also opt in to a Hers smart scale, which ships separately and isn't offered in every state.

You don't need insurance, and Hers doesn't ask about it. HSA and FSA cards can be used, though your provider may ask for a receipt before the payment goes through. Medication can be billed monthly or upfront, depending on the plan you pick.

Getting a prescription

You start with an online intake about your health history and goals, and a state-licensed provider reviews it. In some states that's enough. In others you'll be asked to book a short video or audio visit. If you're already on a GLP-1 elsewhere, Hers says care can often continue without starting from the first dose again.

GLP-1 treatment through Hers isn't available in every state yet, so check yours before you fill out the intake.

Canceling

You can cancel at any time, but the two pieces work differently. Canceling the membership also ends your medication plan and your access to care. Canceling only the medication plan leaves the membership running, and it keeps billing $149 a month until you cancel it too.

Before you sign up:

  • Budget for the membership every month, not just the medication price on the product page.
  • Ask what your dose will cost after the starter months.
  • Hers doesn't sell compounded semaglutide or tirzepatide.

The Index scorecard

Hers scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month28/100
Price Transparency64/100
Nationwide Access24/100
Formulation Options95/100
Clinical Oversight59/100
Contract Flexibility41/100

The bottom line

Hers (Hims & Hers Health, NYSE: HIMS) now sells only FDA-approved branded GLP-1 medications for weight loss — Wegovy, Zepbound, Ozempic, Mounjaro, and the new orforglipron pill 'Foundayo' — rather than compounded semaglutide.

Compare the total cost of other GLP-1 programs and alternatives to Hers before deciding. A clinician should help you choose the right treatment.

Other programs to compare with Hers

These are partners: we may earn a commission if you sign up, at no cost to you.

  • Enhance MDPartner

    Semaglutide modeled $212/mo · Tirzepatide modeled $280/mo

    Enhance MD charges $212 a month for compounded semaglutide and $280 for tirzepatide at every dose, with lab work every six months included; the first month is $100 less.

  • HealthRXPartner

    Semaglutide modeled $190/mo · Tirzepatide modeled $239/mo

    HealthRX charges $190 a month for compounded semaglutide and $239 for tirzepatide month to month; the $99 and $179 it advertises are prepaid twelve-month prices.

  • Bodybuilding Health+Partner

    Semaglutide modeled $179/mo · Tirzepatide modeled $209/mo

    The Bodybuilding.com brand's telehealth arm charges $179 a month for compounded semaglutide and $209 for tirzepatide, with discounts for three, six and twelve months.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to Hers's. See the alternatives to Hers.

Explore more provider reviews

Pricing, states and verification reflect Hers's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Hers's site. Not medical advice; see our disclosure.

← Back to the value leaderboard